Preparation and anti-tumor application of targeted delivery AIEgen for radiotherapy enhancement immunotherapy carrier
The invention discloses preparation of a carrier for enhancing immunotherapy by targeted delivery of AIEgen for radiotherapy and an anti-tumor application. The invention relates to the technical field of biology, in particular to preparation of a carrier for enhancing immunotherapy by targeted deliv...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
08.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention discloses preparation of a carrier for enhancing immunotherapy by targeted delivery of AIEgen for radiotherapy and an anti-tumor application. The invention relates to the technical field of biology, in particular to preparation of a carrier for enhancing immunotherapy by targeted delivery of AIEgen for radiotherapy and anti-tumor application. The invention provides a medicine capable of inhibiting the activity of tumor cells or resisting tumor activity, the active ingredient of the medicine contains VNP (at) TBTP-Au, and the VNP (at) TBTP-Au is composed of active bacteria and TBTP-Au loaded by an active bacteria carrier. The attenuated salmonella VNP20009 is used as a newly synthesized TBTP-Au radiosensitizer transfer carrier, and the immunostimulation effect of the attenuated salmonella VNP20009 is combined, so that tumor radioimmunotherapy is realized, a new strategy is provided for the organic combination of bacteria and image-guided radiotherapy, and a foundation is laid for the combination |
---|---|
Bibliography: | Application Number: CN202310338150 |